LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes
Public ClinicalTrials.gov record NCT00214630. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12-week Randomized, Open-label 3-arm, Parallel Group, Multicenter Phase IIIb Study Comparing Efficacy and Safety of Rosuvastatin 20mg and 40mg With That of Atorvastatin 80 mg in Subjects With Acute Coronary Syndromes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Comparison of rosuvastatin and atorvastatin in subjects with acute coronary syndromes
Study identification
- NCT ID
- NCT00214630
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 825 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2003 (Type not available)
- Primary completion
- Aug 2007 (Actual)
- Completion
- Aug 2007 (Actual)
- Last update posted
- Nov 19, 2010
2003 – 2007
United States locations
- U.S. sites
- 52
- U.S. states
- 27
- U.S. cities
- 52
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | San Diego | California | — | — |
| Research Site | Torrance | California | — | — |
| Research Site | Bridgeport | Connecticut | — | — |
| Research Site | Atlantis | Florida | — | — |
| Research Site | Brandon | Florida | — | — |
| Research Site | Jacksonville | Florida | — | — |
| Research Site | Pensacola | Florida | — | — |
| Research Site | Safety Harbor | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | Aurora | Illinois | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Lombard | Illinois | — | — |
| Research Site | Melrose Park | Illinois | — | — |
| Research Site | Peoria | Illinois | — | — |
| Research Site | Anderson | Indiana | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Des Moines | Iowa | — | — |
| Research Site | Louisville | Kentucky | — | — |
| Research Site | Owensboro | Kentucky | — | — |
| Research Site | Covington | Louisiana | — | — |
| Research Site | Shreveport | Louisiana | — | — |
| Research Site | Annapolis | Maryland | — | — |
| Research Site | Towson | Maryland | — | — |
| Research Site | Ann Arbor | Michigan | — | — |
| Research Site | Pontiac | Michigan | — | — |
| Research Site | Troy | Michigan | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | Saint Paul | Minnesota | — | — |
| Research Site | Tupelo | Mississippi | — | — |
| Research Site | Kansas City | Missouri | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Kalispell | Montana | — | — |
| Research Site | Newark | New Jersey | — | — |
| Research Site | Albuquerque | New Mexico | — | — |
| Research Site | Rochester | New York | — | — |
| Research Site | Asheville | North Carolina | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Fairview Park | Ohio | — | — |
| Research Site | Springfield | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Tulsa | Oklahoma | — | — |
| Research Site | Bend | Oregon | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Danville | Pennsylvania | — | — |
| Research Site | Memphis | Tennessee | — | — |
| Research Site | Amarillo | Texas | — | — |
| Research Site | Beaumont | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Lubbock | Texas | — | — |
| Research Site | Chesapeake | Virginia | — | — |
| Research Site | Burien | Washington | — | — |
| Research Site | Wausau | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00214630, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2010 · Synced Nov 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00214630 live on ClinicalTrials.gov.